Search Results

You searched for : Gilead  

Can One Injection End Decades of HIV Inequality?

The long-acting drug could change the lives of millions of people, offering not just protection but also the promise of a brighter future....
Dec 19

From Daily Pills to 2 Shots Per Year: The Future of HIV Protection

Lenacapavir could lead the way for a future where HIV infections are no longer a global crisis but a chapter in history....
Dec 06

HIV response under lens of indigenous rights

Racism, stigma, and discrimination must be eradicated to protect the human rights of people living with HIV in all communities....
Oct 16

Lenacapavir: India’s Pharmaceutical Giants to Produce a Twice-a-Year Pill Poised to Rewrite HIV Prevention

In the coming years, the impact of Lenacapavir could be felt worldwide, especially in low-income countries where the burden of HIV is greatest....
Oct 04

Why Your Mammogram Might Be More Than Just a Cancer Screening: Insights on Cardiovascular Risk

These findings reflect the ongoing commitment of the medical community to improving outcomes for patients, while also leading the way for future innovations in diagnosis, ...
Sep 17

AIDS response caught in a debt trap

...
Aug 12

Twice-Yearly Injection Shows 100% HIV Protection in Young Women

As the drug moves through regulatory and accessibility phases, there is optimism that it will become a widely available and effective tool in the global ...
Jul 11

Another feather in the cap of treatment as HIV prevention

There is no time to waste if we are to translate these exciting clinical trial results into actual public health impact and expand the toolbox ...
Jun 22

TenSixteen Bio receives $40 million in Series A round

USA-based biosciences startup, TenSixteen jas raised $40 million in its Series A funding round from Foresite Capital and GV....
Jan 29

BioNTech to acquire Kite’s neoantigen TCR Cell Therapy R&D platform and manufacturing facility in Gaithersburg, MD

Pharma merger and acquisition news...
Jul 22

Remdesivir – Antiviral drug for treatment of COVID 19

...
Apr 24

Corona curfew starts in Bhopal to counter recent surge in Covid-19 cases

The curfew has been enforced from April 12, 9 PM till April 19, 6 am...
Apr 13

Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences...
Jan 15

Top Ten Mid Cap Indian Pharma Stocks ; January 2021

Top ten mid cap Indian pharma stocks , January 2021...
Jan 07

RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib

Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material ...
Jan 02

Gilead and Galapagos announce new commercialization and development agreement for Jyseleca

Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease...
Dec 16

New Report From Grantmakers In Aging Offers Recommendations to Improve Care, Increase Inclusion for Older People Living With HIV/AIDS

Grantmakers In Aging, a national membership organization of philanthropies, created Moving Ahead Together: A Framework for Integrating HIV/AIDS and Aging Services to help end ...
Dec 09

Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials

Roche today announced a partnership with Moderna Inc. to utilize the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine ...
Dec 09

WHO drops Gilead's Remdesivir from Prequalification list

With Remdesivir out from benchmark drugs for Covid Gilead could be severely impacted...
Nov 21

WHO Guideline Development Group advises against use of remdesivir for covid-19

Currently no evidence that it improves survival and other important measures ...
Nov 20

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids and shuns ...
Nov 10

Sedor Pharmaceuticals receives US FDA approval for SESQUIENT

Ligand’s Partner Sedor Pharmaceuticals receives US FDA approval for SESQUIENT for the treatment of status epilepticus in adult and paediatric patients ...
Nov 07

ProteoNic announces licensing of its 2G UNic Technology Platform to Gilead Sciences

...
Nov 07

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD....
Nov 06

Everest Medicines receives approval of CTA by China NMPA for phase 3 registration trial of Trodelvy

This trial will enroll approximately 330 HR+/HER2- mBC patients in Mainland China, Taiwan and South Korea...
Nov 02

25 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026